vimarsana.com

Latest Breaking News On - Glycemic sugar - Page 1 : vimarsana.com

Impact Biomedical, Inc. Announces U.S. Patent Allowance of

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is.

United-states
American
Frankd-heuszel
Dss-inc
Impact-biomedical-inc
Trademark-office
Securities-exchange
Precedence-research
Glycemic-sugar
Market-impact
Disease-treatment-market

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) Impact Biomedical Inc. (IBIO), in which DSS Inc.DSS has a significant investment, is thrilled to announce a…

Trademark-office
Impact-biomedical-inc
Glycemic-sugar
News
Ggregator
Reaking-news
Uration
Media

vimarsana © 2020. All Rights Reserved.